兆科眼科-B公布年度业绩 收益大幅增长 积极探索中国境外的许可与合作机会

格隆汇
Mar 24, 2025

格隆汇3月24日丨兆科眼科-B(06622.HK)公告,截至2024年12月31日止年度,集团录得收益人民币69.3百万元,而截至2023年12月31日止年度则为人民币18.8百万元。有关增长主要源于公司根据日期为2020年10月2日的产品许可协议收取有关阿达帕林╱盐酸克林霉素复方凝胶的里程碑付款人民币33.5百万元,令许可收入增加。此外,公司喜见年内的医院覆盖面取得突破,加上成功实行创新的全通路...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10